Ads
related to: crispr therapeutics stockinvesco.com has been visited by 100K+ users in the past month
Search results
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 5 days agoThe Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The...
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 3 days agoDuring this period, the Zacks Medical - Biomedical and Genetics industry, which CRISPR Therapeutics falls in, has gained 5%. The key question now is: What ...
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
Motley Fool via Yahoo Finance· 10 hours agoThis top investor is betting on various big names such as Tesla, her top holding, as well as smaller...
CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.2% After Analyst Downgrade
ETF DAILY NEWS· 7 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0.2% during mid-day trading on Friday after Citigroup lowered their price target on the < ...
CRISPR Therapeutics AG [NASDAQ: CRSP] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 2 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CRISPR ...
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $84.00
ETF DAILY NEWS· 7 days agoCRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price objective dropped by investment analysts at Citigroup from $89.00 to $84.00 in a research ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 hours agoBoth measures beat Wall Street's forecasts. Vertex is also working on a next-generation triple...
7 Stocks You Haven't Heard of (That EVERYONE Should Own)
InvestorPlace· 2 days agoThere are many must-own stocks beyond the mega-caps that aren’t household names but have solid...
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 18 hours agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
Got $500? 3 Pharma Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 5 days agoIf it fails, it can still fall back on its growing CF business, as well as on the soon-to-ramp-up sales of the gene therapy called Casgevy that it...
Ad
related to: crispr therapeutics stock